During the past decade, Holston Medical Group conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 18 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Holston Medical Group" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Pfizer" with 5 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored, "AstraZeneca" with 3 trials sponsored and "Purdue Pharma LP" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holston Medical Group" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Paidion Research, Inc." with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Database Integrations, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Holston Medical Group" are "Type 2 Diabetes Mellitus" (5 trials), "Type 2 Diabetes" (3 trials), "Back Pain Lower Back Chronic" (2 trials), "COVID-19" (2 trials) and "Diabetes Mellitus, Type 1" (2 trials). Many other conditions were trialed in "Holston Medical Group" in a lesser frequency.

Most popular intervention types in "Holston Medical Group" are "Drug" (25 trials), "Other" (7 trials), "Biological" (6 trials), "Behavioral" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Dapagliflozin" (3 trials), "Metformin XR" (3 trials), "Tirzepatide" (3 trials) and "BNT162b2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Holston Medical Group" are 33 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Holston Medical Group". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Holston Medical Group, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Holston Medical Group, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".